A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs
Conditions: Germ Cell Tumor; Seminoma; Non-seminomatous Germ Cell Tumor; Ovarian Germ Cell Tumor Intervention: Drug: Cabozantinib Sponsors: Nabil Adra; Exelixis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials